The impact of methadone maintenance therapy on hepatitis C incidence among illicit drug users (Q34498633)

2 August 2017

title

The impact of methadone maintenance therapy on hepatitis C incidence among illicit drug users (English)

1 reference

2 August 2017

1 reference

Thomas Kerr

1 reference

2 August 2017

Julio Montaner

1 reference

2 August 2017

Evan Wood

1 reference

2 August 2017

Viviane Dias Lima

1 reference

2 August 2017

Nadia Fairbairn

1 reference

2 August 2017

Jason Grebely

1 reference

2 August 2017

Seonaid Nolan

1 reference

2 August 2017

language of work or name

English

0 references

publication date

14 August 2014

1 reference

2 August 2017

1 reference

2 August 2017

volume

109

1 reference

2 August 2017

1 reference

2 August 2017

page(s)

2053-2059

1 reference

Hepatitis C avoidance in injection drug users: a typology of possible protective practices

2 August 2017

cites work

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4229435

Effectiveness of Methadone Maintenance Treatment in Prevention of Hepatitis C Virus Transmission among Injecting Drug Users

7 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4229435

A call for evidence-based medical treatment of opioid dependence in the United States and Canada

7 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4229435

Epidemiology and natural history of HCV infection.

7 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4229435

Global epidemiology of hepatitis C virus infection: new estimates of age-specific antibody to HCV seroprevalence

7 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4229435

Can needle and syringe programmes and opiate substitution therapy achieve substantial reductions in hepatitis C virus prevalence? Model projections for different epidemic settings

7 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4229435

Methadone maintenance therapy outcomes in Iran

7 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4229435

Defining dosing pattern characteristics of successful tapers following methadone maintenance treatment: results from a population-based retrospective cohort study

7 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4229435

The rising prevalence of prescription opioid injection and its association with hepatitis C incidence among street-drug users

7 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4229435

Factors associated with methadone treatment among injection drug users in Bangkok, Thailand

7 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4229435

Global epidemiology of hepatitis B and hepatitis C in people who inject drugs: results of systematic reviews

7 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4229435

A Systematic Review and Meta-Analysis of Interventions to Prevent Hepatitis C Virus Infection in People Who Inject Drugs

7 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4229435

Prevention of HIV infection for people who inject drugs: why individual, structural, and combination approaches are needed

7 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4229435

People who use drugs, HIV, and human rights

7 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4229435

HIV prevention, treatment, and care services for people who inject drugs: a systematic review of global, regional, and national coverage

7 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4229435

Attribution of hepatitis C virus seroconversion risk in young injection drug users in 5 US cities

7 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4229435

Smoking of crack cocaine as a risk factor for HIV infection among people who use injection drugs.

7 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4229435

Acute hepatitis C virus infection in young adult injection drug users: a prospective study of incident infection, resolution, and reinfection

7 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4229435

Methadone maintenance therapy versus no opioid replacement therapy for opioid dependence

7 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4229435

Incidence of hepatitis C in drug injectors: the role of homelessness, opiate substitution treatment, equipment sharing, and community size

7 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4229435

High hepatitis C virus prevalence and incidence among Canadian intravenous drug users

7 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4229435

Incidence and risk factors for hepatitis C seroconversion in injecting drug users in Australia

7 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4229435

The contributions of hepatitis B virus and hepatitis C virus infections to cirrhosis and primary liver cancer worldwide

7 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4229435

Evaluating methamphetamine use and risks of injection initiation among street youth: the ARYS study

7 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4229435

Brief report: Methadone treatment of injecting opioid users for prevention of HIV infection

7 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4229435

Factors associated with methadone maintenance therapy use among a cohort of polysubstance using injection drug users in Vancouver

7 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4229435

Injection drug use and the hepatitis C virus: considerations for a targeted treatment approach--the case study of Canada

7 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4229435

The prevalence of hepatitis C virus infection in the United States, 1988 through 1994

7 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4229435

Do needle exchange programmes increase the spread of HIV among injection drug users?: an investigation of the Vancouver outbreak.

7 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4229435

Methadone maintenance and hepatitis C virus infection among injecting drug users

7 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4229435

Hepatitis C virus incidence among young street-involved IDUs in relation to injection experience

7 July 2018

1 reference

Prevalence of hepatitis C virus infection among injecting drug users in Glasgow 1990-1996: are current harm reduction strategies working?

21 January 2018

1 reference

Barriers to use of free antiretroviral therapy in injection drug users

21 January 2018

1 reference

Highly active antiretroviral therapy and survival in HIV-infected injection drug users.

21 January 2018

1 reference

Characteristics of injection drug users who participate in drug dealing: implications for drug policy.

21 January 2018

1 reference

Opportunities for prevention: hepatitis C prevalence and incidence in a cohort of young injection drug users

21 January 2018

1 reference

Hepatitis C virus transmission dynamics in injection drug users

21 January 2018

1 reference

Four-year follow-up of imprisoned male heroin users and methadone treatment: mortality, re-incarceration and hepatitis C infection

21 January 2018

1 reference

The impact of needle and syringe provision and opiate substitution therapy on the incidence of hepatitis C virus in injecting drug users: pooling of UK evidence.

21 January 2018

1 reference

Audio-computer interviewing to measure risk behaviour for HIV among injecting drug users: a quasi-randomised trial

21 January 2018

1 reference

Simulation study of confounder-selection strategies.

21 January 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4229435

A continuing concern: HIV and hepatitis testing and prevalence among drug users in substitution programmes in Zurich, Switzerland

27 October 2018

1 reference

Staging for antiretroviral therapy among HIV-infected drug users

21 January 2018

1 reference

PubMed

https://pubmed.ncbi.nlm.nih.gov/25041346

inferred from PubMed ID database lookup

12 December 2020

based on heuristic

Natural history of hepatitis C

1 reference

PubMed

https://pubmed.ncbi.nlm.nih.gov/25041346

inferred from PubMed ID database lookup

12 December 2020

based on heuristic

Identifiers

DOI

10.1111/ADD.12682

1 reference

2 August 2017

1 reference

2 August 2017

1 reference